Air India flight from Delhi to Moscow returns midway as pilot tests positive for COVID-19; crew quarantined

Another plane would be sent to Moscow to bring back the stranded Indians, according to Air India officials

Press Trust of India May 30, 2020 17:28:33 IST
Air India flight from Delhi to Moscow returns midway as pilot tests positive for COVID-19; crew quarantined

An Air India flight from Delhi to Moscow on Saturday had to return midway after the airline's ground team found out that one of the pilots had tested positive for novel coronavirus, officials said.

Air India flight from Delhi to Moscow returns midway as pilot tests positive for COVID19 crew quarantined

Representational image. News18

"When the A320 plane, which did not have any passengers as it was heading to Moscow to bring back stranded Indians under Vande Bharat Mission, had reached Uzbekistan's airspace, our team on the ground realised that one of the pilots had tested COVID-positive," senior Air India officials said.

"The flight was immediately asked to return. It came back to Delhi at around 12.30 pm on Saturday," the officials said.

The crew has been quarantined. Another plane would be sent to Moscow to bring back the stranded Indians, according to the officials.

Updated Date:

also read

Dengue cases climb in West Bengal, 840 new infections in run-up to festival
India

Dengue cases climb in West Bengal, 840 new infections in run-up to festival

Most of the cases have been reported from North 24 Parganas, Howrah, Kolkata, Hooghly, Murshidabad, South 24 Parganas, Jalpaiguri and Darjeeling districts

COVID-19: Active Covid cases in India rise to 46,342
Health

COVID-19: Active Covid cases in India rise to 46,342

The active cases comprise 0.10 per cent of the total infections, while the national COVID-19 recovery rate increased to 98.71 per cent.

WHO no longer recommends use of 2 Covid-19 antibody therapies: BMJ
World

WHO no longer recommends use of 2 Covid-19 antibody therapies: BMJ

The “strong” recommendation replaces previous conditional recommendations for their use and is based on emerging evidence from laboratory studies that these drugs are not likely to work against currently circulating variants, such as Omicron